This work is part of a retrospective collection of 179 electronic theses and dissertations (ETDs) from the VCU Libraries pilot ETD system that were designated as available only to VCU users. Please contact us at if you have questions or if you are the author of one of these and would like to release it for online public access.

Non-VCU users: Please talk to your librarian about requesting this thesis through interlibrary loan.

Defense Date

2006

Document Type

Thesis

Degree Name

Master of Science

Department

Pharmacy

First Advisor

Dr. David A. Holdford

Abstract

Objective To describe off-label utilization of erythropoietic agents in ICU patients.Methods A retrospective, observational study design was used to describe off-label utilization of erythropoietin alfa and darbepoetin alfa by 91,357 patients in the ICU during January 2002- June 2004 at 433 U.S. hospitals. Results Approximately 62% of patients received erythropoietic agents off-label in the ICU compared to 49% in the non-ICU population. Off-label use in the ICU was more likely in teaching hospitals, in larger sized hospitals, in females, for certain physician specialties, and in different regions of the U.S., The longer the hospital stay, the less likely off-label prescribing occurred. ConclusionsOff-label use of erythropoietic agents was common in the ICU. Multiple factors affected off-label use in the ICU although no single one was dominant.

Comments

Part of Retrospective ETD Collection, restricted to VCU only.

Rights

© The Author

Is Part Of

VCU University Archives

Is Part Of

VCU Theses and Dissertations

Date of Submission

June 2008

Share

COinS